INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1767170794-GLP-1-peptide-chain]( "History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era")
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 EraPeptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
![GettyImages-1185624320-scientist-lab-smiling]( "Selecting A CDMO For Custom Activated PEGs")
Selecting A CDMO For Custom Activated PEGsCustom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
![GettyImages-2152418334-antibody-drug-conjugate-render]( "Thunderstruck By Antibody-Drug Conjugates")
Thunderstruck By Antibody-Drug ConjugatesAntibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.
-
![GettyImages-2002525379-production-solid-dose-capsules]( "Softgel Formulation Strategies For Challenging Oral Compounds")
Softgel Formulation Strategies For Challenging Oral CompoundsExplore strategies to solve solubility and permeability challenges, boost oral bioavailability, and ensure consistent absorption — reducing risk and unlocking complex molecules.
-
Managing Process Knowledge Throughout Drug Development And Manufacturing10/21/2025
Discover how digitalizing recipe and risk management helps life sciences teams accelerate drug development, streamline technology transfers, and simplify compliance to improve data integrity.
-
Overcoming Excipient Risks And Challenges For Parenteral Formulations8/27/2025
Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.
-
Direct qPCR Amplification From Human Urine Samples6/9/2026
Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.
-
Complementary Methodologies For Analysis Of NISTmAb Impurities2/27/2026
Gain insight into how SEC and CE‑SDS complement each other to assess monoclonal antibody size variants, offering stronger insight into aggregates, fragments, and overall purity.
-
Thermofluor Screening For Injectable Protein Formulations9/15/2025
The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.
DRUG DEVELOPMENT SOLUTIONS
-
![Waters Acquity]( "ACQUITY Premier Analytical Solution")
The ACQUITY Premier Solution enables your lab to make informed decisions and reduce risk with stronger analytical capabilities to detect more of your sample components from the very beginning.
-
![HC-IS]( "Pharmaceutical Containment Isolators: HC-IS Series")
The primary characteristic of Containment Isolators is maximizing operator protection: Tema Sinergie Containment Isolator systems have been designed for handling high potent compounds and offer guaranteed very high levels of user protection.
-
![Phenomenex Zebron]( "Columns To Optimize Your GC Analysis")
Optimize Your GC Analysis with Zebron GC Columns
Zebron GC columns are engineered with quality of analysis in mind to better support scientists' research and regulatory analysis for environmental, food safety, food quality, forensics, pharma, fuels, and specialty chemicals.
-
![Chip-R1™]( "Chip-R1™ Rigid Chip")
Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.
-
![GettyImages-923626190-magnifying-glass-pill-tablets-powder]( "API Stability Combined With Rapid Disintegration")
Enhance tablet effectiveness across various dosages with an excipient that offers excellent compressibility and stability for APIs, which eliminates the need for intense processing and provides rapid disintegration.
